BIOMATERIALS

Scope & Guideline

Driving Excellence in Biomaterials Research and Application

Introduction

Delve into the academic richness of BIOMATERIALS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0142-9612
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1980 to 2025
AbbreviationBIOMATERIALS / Biomaterials
Frequency36 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal "BIOMATERIALS" focuses on advancing the field of biomaterials through innovative research that emphasizes the design, application, and evaluation of materials used in biological and medical applications. The journal aims to bridge the gap between materials science and biological research, providing insights into how materials interact with biological systems and how they can be optimized for therapeutic use.
  1. Biomaterials for Regenerative Medicine:
    Research in this area focuses on the development and application of biomaterials that can support tissue regeneration and repair, including scaffolds, hydrogels, and 3D printed constructs designed to enhance healing in various tissues.
  2. Nanomedicine and Drug Delivery Systems:
    This scope encompasses the design and application of nanomaterials for targeted and controlled drug delivery, enhancing therapeutic efficacy while minimizing side effects, particularly in cancer treatment and chronic diseases.
  3. Bioengineering and Tissue Engineering:
    The journal highlights studies that integrate engineering principles with biological systems, focusing on the creation of functional tissues and organs, including organ-on-a-chip technologies and bioprinting.
  4. Immunomodulation and Therapeutic Applications:
    Research that explores how biomaterials can modulate immune responses to improve therapeutic outcomes, particularly in cancer immunotherapy and regenerative medicine.
  5. Biocompatibility and Safety Evaluation:
    The journal publishes studies assessing the biocompatibility, toxicity, and long-term effects of biomaterials in biological systems, which are critical for their clinical translation.
  6. Smart Biomaterials and Responsive Systems:
    This area includes the development of materials that respond to environmental stimuli (e.g., pH, temperature, light) for dynamic therapeutic applications.
The journal "BIOMATERIALS" has witnessed a rise in innovative research themes that reflect emerging trends in the biomaterials field. These themes often focus on the integration of advanced technologies and interdisciplinary approaches to address complex biological challenges.
  1. Advanced Nanotherapeutics:
    There is a growing emphasis on the development of nanomaterials that can deliver drugs or therapeutic agents with high precision, including nanocarriers that enhance the efficacy of immunotherapies and chemotherapies.
  2. 3D Bioprinting and Organ-on-a-Chip Technologies:
    The trend towards creating complex tissue structures using 3D bioprinting techniques is increasing, along with the development of organ-on-a-chip systems that mimic human organ functions for drug testing and disease modeling.
  3. Biomaterials for Cancer Immunotherapy:
    Research is trending towards the use of biomaterials as platforms for cancer immunotherapy, focusing on how these materials can enhance immune responses and target tumor microenvironments.
  4. Smart and Responsive Biomaterials:
    There is an emerging interest in biomaterials that respond to specific stimuli (light, temperature, pH), allowing for on-demand drug release and dynamic therapeutic applications.
  5. Microenvironment Engineering:
    An increasing number of studies are focusing on how the engineered microenvironment can influence cell behavior, particularly in the context of stem cell therapy and tissue regeneration.
  6. Sustainable and Green Biomaterials:
    There is a rising trend towards developing environmentally friendly biomaterials derived from natural sources, emphasizing sustainability and biocompatibility.

Declining or Waning

While "BIOMATERIALS" continues to expand its research frontiers, certain themes have shown a decline in focus or frequency of publication in recent years. These themes may reflect shifts in research interests or advancements in technology that have rendered previous approaches less relevant.
  1. Traditional Biomaterials without Functionalization:
    There has been a noticeable decrease in studies focusing solely on traditional biomaterials (such as simple hydrogels or polymers) without advanced functionalization or modification to enhance their properties or applications.
  2. In vitro Studies without Translation to In Vivo Models:
    Research that remains solely within in vitro studies without progressing to in vivo validation is declining, as there is a greater emphasis on translational research that can lead to practical applications in clinical settings.
  3. Non-targeted Drug Delivery Approaches:
    As precision medicine becomes more prominent, there is a waning interest in non-targeted drug delivery systems, with more focus shifting towards targeted and personalized therapies.
  4. Static Biomaterial Studies:
    Static studies that do not incorporate dynamic or responsive elements in biomaterials are becoming less frequent, as there is a growing interest in materials that can adapt to physiological conditions.

Similar Journals

Biomaterials Advances

Advancing the Frontiers of Biomaterials Research
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

Biomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.

Advanced Therapeutics

Advancing the frontiers of medical innovation.
Publisher: WILEYISSN: Frequency: 12 issues/year

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

Bioactive Materials

Catalyzing Discoveries in Bioactive Materials and Applications
Publisher: KEAI PUBLISHING LTDISSN: Frequency: 12 issues/year

Bioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.

Advanced Healthcare Materials

Redefining Healthcare Through Advanced Materials
Publisher: WILEYISSN: 2192-2640Frequency: 12 issues/year

Advanced Healthcare Materials, published by WILEY, is a leading journal in the interdisciplinary fields of biomaterials, biomedical engineering, and pharmaceutical science. With its ISSN 2192-2640 and E-ISSN 2192-2659, the journal provides a platform for innovative research that encompasses the design, fabrication, and application of advanced materials in healthcare settings. Recognized for its high impact, it boasts a Q1 ranking in several categories, including a notable rank of #7/183 in Pharmaceutical Science and 14/137 in Biomaterials according to Scopus rankings. This reflects the journal’s commitment to publishing cutting-edge studies that push the boundaries of science and technology in medicine. Although it operates under a subscription model, articles published in this journal significantly impact the global research community and play a crucial role in the advancement of healthcare technologies. With a publication history from 2012 to 2024, Advanced Healthcare Materials remains an essential resource for researchers, professionals, and students engaged in the groundbreaking intersections of materials science and healthcare.

Materials

Fostering collaboration in the evolving landscape of materials science.
Publisher: MDPIISSN: Frequency: 24 issues/year

Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.

Biomaterials Science

Connecting science and application in the realm of biomaterials.
Publisher: ROYAL SOC CHEMISTRYISSN: 2047-4830Frequency: 24 issues/year

Biomaterials Science is a premier journal published by the Royal Society of Chemistry that serves as a leading platform for researchers and professionals in the fields of Biomedical Engineering and Materials Science. With an impressive impact factor bolstered by its Q1 quartile ranking in both disciplines, this journal has positioned itself at the forefront of cutting-edge research, showcasing innovative materials and applications that drive advancements in healthcare and technology. Since its inception in 2013, Biomaterials Science has been committed to disseminating high-quality, peer-reviewed articles that promote scientific knowledge and collaboration among academia and industry. With a global readership and a focus on open access, researchers are encouraged to share their findings to facilitate the development of transformative biomaterials and their applications. Join a vibrant community of scholars as we explore the future of biomaterials through this esteemed publication, enhancing both scientific inquiry and practical application.

Materials Today Bio

Connecting materials science with the future of biological innovation.
Publisher: ELSEVIERISSN: 2590-0064Frequency: 4 issues/year

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

Progress in Biomaterials

Transforming Ideas into Applications in Biomaterials
Publisher: SPRINGER HEIDELBERGISSN: 2194-0509Frequency: 4 issues/year

Progress in Biomaterials is a premier journal published by Springer Heidelberg, dedicated to advancing the field of biomaterials through the dissemination of high-quality research articles, reviews, and case studies. The journal, with an ISSN of 2194-0509 and an E-ISSN of 2194-0517, holds an esteemed position within both the Biomaterials and Chemical Engineering fields, as evidenced by its rankings in the Q2 and Q1 quartiles, respectively. With its convergence over the years from 2013 to 2023, it has maintained a strong impact on scientific discourse, ranking #15 in Chemical Engineering and #30 in Biomaterials according to Scopus metrics. The journal is based in Heidelberg, Germany, and aims to provide an open platform for interdisciplinary collaboration amongst researchers, professionals, and students alike, fostering innovation and progress in biomaterials research. As a crucial resource for those engaged in this dynamic field, it empowers authors and readers to explore the latest trends, technologies, and applications in biomaterials development.

Materials Science & Engineering C-Materials for Biological Applications

Advancing biomaterials for a healthier future.
Publisher: ELSEVIERISSN: 0928-4931Frequency: 12 issues/year

Materials Science & Engineering C-Materials for Biological Applications is a premier journal published by ELSEVIER, dedicated to advancing the field of biomaterials through interdisciplinary research. With a robust ISSN of 0928-4931, this journal has made its mark in the realms of Chemical Engineering and Materials Science, achieving impressive Scopus rankings within its categories, namely Rank #16/151 in Bioengineering (89th percentile) and Rank #13/112 in Biomaterials (88th percentile). Although the journal's coverage in Scopus has been discontinued since 2021, it remains a critical resource for researchers, professionals, and students eager to explore innovative materials and their applications in biological contexts. The journal’s open access policy enhances its accessibility, fostering a global exchange of knowledge and inspiring future advancements in the field of materials science.

Tissue Engineering Part B-Reviews

Advancing the Frontiers of Tissue Engineering.
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3368Frequency: 6 issues/year

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.